Difficulty: Medium
Average Score: 78%
Practice
The following is NOT an advantage of rivaroxiban and dabigatran over warfarin:
Correct answer
C
Rationale
Rivaroxaban and dabigatran are direct oral anticoagulants (DOACs) that offer several advantages over warfarin in terms of convenience and safety. The correct answer, option C, states that no dose adjustment is needed in renal failure, which is not an advantage of these drugs compared to warfarin.
Option A, more rapid onset and offset, is a key advantage of rivaroxaban and dabigatran over warfarin. These DOACs have a quicker onset of action and shorter half-lives compared to warfarin, allowing for more rapid anticoagulation and reversal if needed. Option B, no monitoring by INR required, is another advantage of DOACs as regular INR monitoring, necessary for warfarin, is not needed with rivaroxaban and dabigatran.
Option D, less drug interactions with CYP450 interacting drugs, is also a benefit of DOACs. Warfarin has numerous drug interactions due to its metabolism through the CYP450 system, whereas rivaroxaban and dabigatran have fewer interactions, making them more predictable and easier to manage in terms of interactions.
In an educational context, understanding the advantages and limitations of different anticoagulants is essential for healthcare professionals, especially for those preparing for exams like the NCLEX. Knowing the specific characteristics of each drug helps in making informed decisions about anticoagulant therapy based on individual patient factors and clinical scenarios.
Option A, more rapid onset and offset, is a key advantage of rivaroxaban and dabigatran over warfarin. These DOACs have a quicker onset of action and shorter half-lives compared to warfarin, allowing for more rapid anticoagulation and reversal if needed. Option B, no monitoring by INR required, is another advantage of DOACs as regular INR monitoring, necessary for warfarin, is not needed with rivaroxaban and dabigatran.
Option D, less drug interactions with CYP450 interacting drugs, is also a benefit of DOACs. Warfarin has numerous drug interactions due to its metabolism through the CYP450 system, whereas rivaroxaban and dabigatran have fewer interactions, making them more predictable and easier to manage in terms of interactions.
In an educational context, understanding the advantages and limitations of different anticoagulants is essential for healthcare professionals, especially for those preparing for exams like the NCLEX. Knowing the specific characteristics of each drug helps in making informed decisions about anticoagulant therapy based on individual patient factors and clinical scenarios.